( S )- N -[1-(3-Morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: An Orally Bioavailable KCNQ2 Opener with Significant Activity in a Cortical Spreading Depression Model of Migraine
Year: 2003
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm034073f
Authors: Yong-Jin Wu, Christopher G. Boissard, Corinne Greco, Valentin K. Gribkoff, David G. Harden, Huan He, Alexandre L'Heureux, Shing Hong Kang, Gene G. Kinney, Ronald J. Knox, Joanne Natale, Amy E. Newton, Sanna Lehtinen-Oboma, Michael W. Sinz, Digavalli V. Sivarao, John E. Starrett,, Li-Qiang Sun, Svetlana Tertyshnikova, Mark W. Thompson, David Weaver, Henry S. Wong, Lei Zhang, Steven I. Dworetzky
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1975510544
